Back to search

Spain· ES:53025

STUGERON 75 MG CAPSULAS DURAS

A medicinal product containing cinarizina, registered in Spain by Esteve Pharmaceuticals S.A..

Checked against AEMPS CIMA (Spain) on

Informational only — not a medical device.

SOURCE REGISTER · ESAEMPS CIMA (Spain)normalisedSTUGERON 75 MG CAPSULAS DURASATC—REGISTER NO.ES:53025PACKS LISTED1CHECKEDSeptember 12, 2026

The record

At a glance

AEMPS CIMA (Spain)
Active substance
cinarizina
Manufacturer
Esteve Pharmaceuticals S.A.
Country
Spain (ES)
ATC code
—
Reimbursed
Not published by this register
Source register
AEMPS CIMA (Spain)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • cima_codigo
    827600
    30
    EUR 3.33

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cinarizina in 8 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cinarizina products

Authorised across Europe · EMA

The same active substance is authorised in 19 EEA countries. Names it is sold under:

  • Belgium · Cinnarizine Eg, Stugeron
  • Bulgaria · Цинаризин Абр, Цинаризин Инбиотех
  • Cyprus · Cinnaron
  • Czechia · Stugeron
  • Estonia · Cinnaron
  • United Kingdom (Northern Ireland) · Cinnarizine Generics Uk, Cinnarizine Osgen Pharmaceuticals
  • Hungary · Stugeron
  • Ireland · Stugeron
  • Italy · Cinazyn, Toliman
  • Liechtenstein · Stugeron
  • Lithuania · Cinnarizin Actavis, Cinnarizin Sopharma
  • Luxembourg · Stugeron
  • Latvia · Cinnarizin, Cinnarizin Actavis
  • Malta · Stugeron
  • Netherlands · Cinnarizine Aurobindo, Cinnarizine Kruidvat
  • Poland · Cinnarizinum Aflofarm, Cinnarizinum Hasco
  • Portugal · Cinon Forte, Stugeron
  • Romania · Cinarizina Arena, Cinarizina Laropharm
  • Slovakia · Cinarizin Forte Sandoz, Cinarizin Sandoz

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of AEMPS CIMA (Spain). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/33e91865-8a18-4fa6-8316-5ae7b88793af
GET /v1/drugs/33e91865-8a18-4fa6-8316-5ae7b88793af?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "cpresc": "Medicamento Sujeto A Prescripción Médica",
  "estado": "{\"aut\":191977200000}",
  "nregistro": "53025",
  "substance": "cinarizina"
}

See everything about cinarizina.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.